We recognise the need for a well-defined research agenda that bridges the gap between the children’s and adult oncology research worlds. TYAC is taking the lead on building a new focus on research that is dedicated to the very specific needs of teenage and young adult cancer treatment and care which will help change the future of teenage and young adult (TYA) cancer care and improve outcomes for young people with cancer.
Our medical and scientific expertise, alongside the recent TYA PSP puts us in a strong position to prioritise areas of unmet need and offer funding for specific research projects.
Our aim over the next few years is to increase our investment in research through the following ways:
Our Research Strategy outlines our exciting plans to significantly increase our funding of research. It sets out our research priorities, and how we plan to fund and support research.
TYAC is part of Children's Cancer and Leukaemia Group (CCLG), which is a member of the Association of Medical Research Charities (AMRC). This means the processes we use to select which research projects to fund (including peer review) have been assessed to ensure they are of the highest standards, funding only the best research and researchers.
TYAC’s process of awarding new research grants is based on guidance from the AMRC, as part of CCLG's membership. This provides TYAC with a consistent process for all competitive research applications.
At the heart of this process is a rigorous system for peer review, ensuring that all new research funded by TYAC has been subject to independent scrutiny by those with expertise (peers) in teenage and young adult oncology.
It is the advice of independent experts about the scientific quality of research that informs decisions about which proposals are funded. The aim of this process is to draw from leading insight from across the world to help guide the most effective use of TYAC's resources to help maximise the impact of funding.
TYAC’s process for awarding new research grants is based on the steps recommended by the AMRC meaning that independent external peer review is steering the process.
Excellent research governance is at the heart of our research decision making. Our independent Research Advisory Group (RAG) overseas our research grant rounds. All of our RAG members and external peer reviewers are asked to declare any Conflicts of Interest and adhere to our Grant Review Code of Conduct. Following peer review, the RAG will discuss and rank the applications for funding.
Final approval comes from our Board of Trustees (which may be delegated to our Executive in the case of Special Named Funds and restricted funds), or the Board of Trustees of the partner charity if the funding is not directly from TYAC.
TYAC's parent charity, CCLG, is a member of the AMRC. The AMRC is a membership organisation of the leading medical and health research charities in the UK.
Working with member charities and partners, they aim to support the sector’s effectiveness and advance medical research by developing best practice, providing information and guidance, improving public dialogue about research and science, and influencing government policy.
As a member of the AMRC, we support their statement on the use of animals in research and their statement on supporting research in universities.